We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | NYSE:ABBV | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.835 | 0.51% | 163.475 | 163.58 | 161.14 | 162.73 | 1,658,277 | 18:14:19 |
From May 2022 to May 2024
By Colin Kellaher
AbbVie Inc. on Tuesday said it named Robert Michael vice chairman and president.
Mr. Michael, 51 years old, had been serving chief financial officer of the North Chicago, Ill., biopharmaceutical company since 2018 and added the title of vice chairman of finance and commercial operations last December.
AbbVie said Scott Reents, 55, will now serve as executive vice president and chief financial officer. Mr. Reents, 55, had been vice president of tax and treasury.
Messrs. Michael and Reents have been with AbbVie since its 2013 spinoff from Abbott Laboratories.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 28, 2022 09:51 ET (13:51 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year AbbVie Chart |
1 Month AbbVie Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
